Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2Stomach Neoplasms 1Pancreatitis, Chronic 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Hematologic Neoplasms 1Duodenal Neoplasms 1Cholangiocarcinoma 1Bile Duct Neoplasms 1

Interventions

Gemcitabine 13Oxaliplatin 9Capecitabine 6lenvatinib 5apatinib 5Cisplatin 5tislelizumab 4Surgical Procedures, Operative 4Radiofrequency Ablation 4Neoadjuvant Therapy 4Fluorouracil 4toripalimab 3sintilimab 3Radiotherapy 3Leucovorin 3Irinotecan 3regorafenib 2pembrolizumab 2durvalumab 2camrelizumab 2Stents 2Photochemotherapy 2Immunotherapy 2Hepatectomy 2Folfox protocol 2Everolimus 2Drug Therapy 2Cholangiopancreatography, Endoscopic Retrograde 2Blood Specimen Collection 21-phenyl-3,3-dimethyltriazene 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Cholangiocarcinoma × Enteral Nutrition × Clear all
NCT01642875 2016-11-23

Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy

Medical University of Warsaw

Phase 4 Unknown
96 enrolled
Gastrointestinal

Duodenal Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma, Pancreatitis, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡